-
Report details
-
16
Figures
-
35
Tables
-
Chapter 1: Executive Summary
-
Industry at a Glance
-
Scope and Methodology
-
Size and Growth of the Market
-
Key Issues and Trends Affecting the Market
-
Competitive Outlook
-
Conclusion Highlights
-
Chapter 2: Introduction
-
Chapter 3: Issues and Trends
-
At-Home Testing
-
Insurance Coverage
-
Multiplex Testing
-
EUAs and Public Health Emergency Expiration
-
New Variants On the Horizon
-
Chapter 4: COVID-19 Immunoassay Testing
-
Overview
-
Enzyme-linked Immunosorbent Assay (ELISA)
-
Mass Spectrometry
-
Rapid
-
Products
-
Market Size and Growth
-
Competitive Market Share
-
Chapter 5: COVID-19 Molecular Testing
-
Overview
-
Products
-
Market Size and Growth
-
Competitive Market Share
-
Chapter 6: Total COVID-19 Testing Market Summary
-
Market Overview
-
Market Segment by Test Type/Site
-
Laboratory Based
-
Point of Care
-
Market by Region
-
Competitive Analysis
-
Chapter 7: Selected Market Participants
-
Abbott
-
Company Overview
-
COVID-19
-
Access Bio, Inc
-
Company Overview
-
COVID-19
-
Becton-Dickinson
-
Company Overview
-
COVID-19
-
bioMérieux
-
Company Overview
-
COVID-19
-
Bio-Rad
-
Company Overview
-
COVID-19
-
Cue Health
-
Company Overview
-
COVID-19
-
Danaher Corporation
-
Company Overview
-
COVID-19
-
DiaSorin S.p.A.
-
Company Overview
-
COVID-19
-
ELITech Group S.A.S.
-
Company Overview
-
COVID-19
-
Genedrive plc
-
Company Overview
-
COVID-19
-
Hologic, Inc
-
Company Overview
-
COVID-19
-
LumiraDx UK Limited
-
Company Overview
-
COVID-19
-
OraSure Technologies, Inc.
-
Company Overview
-
COVID-19
-
PerkinElmer, Inc
-
Company Overview
-
COVID-19
-
QIAGEN N.V.
-
Company Overview
-
COVID-19
-
QuantuMDx Group, Ltd.
-
Company Overview
-
COVID-19
-
QuidelOrtho Corporation
-
Company Overview
-
COVID-19
-
Roche Diagnostic Corporation
-
Company Overview
-
COVID-19
-
Seegene, Inc
-
Company Overview
-
COVID-19
-
Siemens Healthineers GmbH
-
Company Overview
-
COVID-19
-
Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)
-
Company Overview
-
COVID-19
-
ThermoFisher Scientific
-
Company Overview
-
COVID-19
|
COVID-19 Testing Markets, 2023
24 Apr 2023
COVID-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in COVID-19 Testing Markets, 2023.
The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of a wide selection of diagnostic tests in all markets. Diagnostics have been critical in the response to COVID-19.
This report provides market sizing and estimates for COVID-19 tests with discussion of market impacts of COVID-19.
Some of the key topics and trends explored include:
- At-Home Testing
- Insurance Coverage
- Multiplex Testing
- Expiration of Public Health Emergency
- New Variants on the Horizon
- Immunoassay Testing
- Molecular Testing
Page Count: 131
Table of Contents
-
Chapter 1: Executive Summary
-
Industry at a Glance
-
Scope and Methodology
-
Size and Growth of the Market
-
Key Issues and Trends Affecting the Market
-
Competitive Outlook
-
Conclusion Highlights
-
Chapter 2: Introduction
-
Chapter 3: Issues and Trends
-
At-Home Testing
-
Insurance Coverage
-
Multiplex Testing
-
EUAs and Public Health Emergency Expiration
-
New Variants On the Horizon
-
Chapter 4: COVID-19 Immunoassay Testing
-
Overview
-
Enzyme-linked Immunosorbent Assay (ELISA)
-
Mass Spectrometry
-
Rapid
-
Products
-
Market Size and Growth
-
Competitive Market Share
-
Chapter 5: COVID-19 Molecular Testing
-
Overview
-
Products
-
Market Size and Growth
-
Competitive Market Share
-
Chapter 6: Total COVID-19 Testing Market Summary
-
Market Overview
-
Market Segment by Test Type/Site
-
Laboratory Based
-
Point of Care
-
Market by Region
-
Competitive Analysis
-
Chapter 7: Selected Market Participants
-
Abbott
-
Company Overview
-
COVID-19
-
Access Bio, Inc
-
Company Overview
-
COVID-19
-
Becton-Dickinson
-
Company Overview
-
COVID-19
-
bioMérieux
-
Company Overview
-
COVID-19
-
Bio-Rad
-
Company Overview
-
COVID-19
-
Cue Health
-
Company Overview
-
COVID-19
-
Danaher Corporation
-
Company Overview
-
COVID-19
-
DiaSorin S.p.A.
-
Company Overview
-
COVID-19
-
ELITech Group S.A.S.
-
Company Overview
-
COVID-19
-
Genedrive plc
-
Company Overview
-
COVID-19
-
Hologic, Inc
-
Company Overview
-
COVID-19
-
LumiraDx UK Limited
-
Company Overview
-
COVID-19
-
OraSure Technologies, Inc.
-
Company Overview
-
COVID-19
-
PerkinElmer, Inc
-
Company Overview
-
COVID-19
-
QIAGEN N.V.
-
Company Overview
-
COVID-19
-
QuantuMDx Group, Ltd.
-
Company Overview
-
COVID-19
-
QuidelOrtho Corporation
-
Company Overview
-
COVID-19
-
Roche Diagnostic Corporation
-
Company Overview
-
COVID-19
-
Seegene, Inc
-
Company Overview
-
COVID-19
-
Siemens Healthineers GmbH
-
Company Overview
-
COVID-19
-
Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)
-
Company Overview
-
COVID-19
-
ThermoFisher Scientific
-
Company Overview
-
COVID-19
|
More information about this product
Other Users Also Viewed
18 Apr 2023
NOW IN TEN EDITIONS!
While tests run on lab-based analyzers in hospitals and reference labs remain the bedrock of IVD revenues, point of care has always been seen as the growth area. For as long as Kalorama Information has covered point of care…
|